No, furosemide IV and PO are NOT equivalent on a 1:1 basis
When converting from oral to intravenous furosemide, the IV dose should be 1 to 2.5 times the home oral dose, reflecting the approximately 50% oral bioavailability of furosemide. 1
Bioavailability Difference
The fundamental reason for non-equivalence is oral furosemide has only 50-64% bioavailability compared to IV administration 2, 3. This means:
- Only about half of an oral dose reaches the systemic circulation and the site of action in the loop of Henle
- IV administration delivers nearly 100% of the drug to the active site
- Significantly more furosemide is excreted in urine following IV injection than after oral administration 2, 3
Guideline-Based Dosing Recommendations
The 2019 ACC Expert Consensus provides explicit conversion guidance 1:
For patients already on loop diuretics:
- Convert oral dose to IV dose of 1-2.5 times the home oral dose
- Example: If taking furosemide 40 mg PO daily, give 40-100 mg IV (typically start with 80 mg IV)
For diuretic-naive patients:
The 2016 ESC Guidelines similarly recommend that initial IV dose should be at least equivalent to the oral dose 4, though this represents a conservative minimum rather than true bioequivalence.
Pharmacokinetic Considerations
Despite delivering only half the drug amount to the active site, oral furosemide can produce similar total natriuretic response to IV dosing due to pharmacodynamic factors 6:
- Oral administration maintains drug at the "maximally efficient" concentration (21.5 μg/min) more persistently
- IV boluses produce very high peak concentrations that exceed the steep portion of the dose-response curve
- The time course of drug delivery matters as much as total amount delivered
However, this does NOT mean doses are 1:1 equivalent—it means that when properly dosed accounting for bioavailability, similar clinical effects can be achieved.
Clinical Implications
In acute heart failure requiring hospitalization:
- Use IV furosemide at 1-2.5× the oral dose for faster, more reliable diuresis 1, 7
- Oral bioavailability is particularly reduced in patients with gut edema from congestion 8
- IV route bypasses absorption issues and provides more predictable response
When transitioning from IV to oral:
- The oral dose typically needs to be higher than the IV dose that was effective
- Monitor weight, urine output, and symptoms closely during transition 1
Common Pitfall
Do not assume 1:1 equivalence when converting between routes. Using the same milligram dose IV as PO will result in approximately double the drug exposure and potentially excessive diuresis, electrolyte disturbances, and renal dysfunction. Conversely, using the same dose PO as was effective IV may result in inadequate diuresis.
The practical conversion is: Oral dose ≈ 2× IV dose (or inversely, IV dose ≈ 0.5× oral dose) to account for the ~50% oral bioavailability 2, 3, 6, 9.